CHIEF WRITER AUTHORITIES have amended regulations governing the production of cannabis for medicinal and scientific purposes, introducing stricter oversight, expanding regulatory definitions and placing the Medicines Control Authority of Zimbabwe (MCAZ) at the centre of licensing and enforcement.The changes are contained in the Dangerous Drugs (Production of Cannabis for Medicinal and Scientific Use) (Amendment) Regulations,…
To access this content, please purchase a subscription by clicking the button below and select a package of your choice!
Subscriptions